Simris Group AB
Pioneering next-generation ADC payloads using proprietary cyanobacterial science.
Oversigt
- 5–9
- Medarbejdere
- 150–199t SEK
- Omsætning
- 2011
- Grundlagt
Beskrivelse
Simris is a biotechnology company dedicated to revolutionizing cancer treatment through its proprietary pipeline of next-generation ADC payloads. These payloads are born from world-class cyanobacterial science, proprietary conjugation methods, and collaborations with leading research institutions. T...